Roche

• orlistat

  Reversible inhibitor of gastric and pancreatic lipases, reducing dietary fat absorption.

  ApprovedSmall moleculeLipid and ceramide metabolismLIPCobesityoverweight

• fenebrutinib

  Inhibits Bruton's tyrosine kinase (BTK) to modulate B cell and myeloid cell activation.

  Phase 3Small moleculeNF-κB signallingInflammationmultiple sclerosisprimary progressive multiple sclerosis

• obinutuzumab

  Anti-CD20 monoclonal antibody that depletes B cells

  Phase 3AntibodyInflammationMS4A1primary membranous nephropathy

9 more assets

• Harmonization of Lipoprotein(a) Immunoassays with the IFCC- Endorsed Reference Measurement Procedure Validated in Patient Samples and Multiple Routine testing as A Second Step Towards Apolipoprotein Standardization

  Journal of atherosclerosis and thrombosis23 Sept 2026

• Cervical Cancer Screening Activity at an Accredited Centre in Romania, 2018-2025: COVID-19 Disruption, Recovery and the Transition to Primary HPV Testing

  Healthcare (Basel, Switzerland)15 Sept 2026

• Acting on the Call Towards Elimination: Diagnostic Accuracy and Acceptability of Human Papilloma Virus Self-Sampling Versus Clinician-Collected Specimens in Bahrain

  Research Square30 Aug 2026

• Monitoring ovarian reserve dynamics via a high-sensitivity anti-Müllerian hormone assay in premenopausal breast cancer patients undergoing chemotherapy

  Human reproduction (Oxford, England)28 Aug 2026